Board Member
Contineum Therapeutics, Inc. (CTNM)Equibles does not estimate personal net worth.
Get an email with a short summary when Contineum Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CTNM alertsCarmine N. Stengone is recorded as Board Member and CEO at Contineum Therapeutics, Inc. (CTNM). The newest filing on record that lists Carmine N. Stengone as Board Member and CEO at Contineum Therapeutics, Inc. (CTNM) is dated April 30, 2026. The proxy statement of Contineum Therapeutics, Inc. reports total compensation of $3,409,448 for Carmine N. Stengone in fiscal 2025, including a base salary of $655,620. Disclosed compensation is on record for 3 fiscal years. Carmine N. Stengone has spoken on 2 investor events across 1 company, most recently for Contineum Therapeutics, Inc. on June 9, 2026. Contineum Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Contineum Therapeutics, Inc. includes Peter T. Slover (CFO), John S. Healy (General Counsel), Diego Miralles (Board Member) and 6 others.
“Corinne, nice to meet you, and thanks to the Goldman team for allowing us to join on the fire side. This is a catalyst-rich year for us. So I think the main focus is going to be around LPA1.”
“And just to set the stage for the study that Nevin's talking about, this was a small exploratory phase 1D study. The goal was to enroll 40 patients in two different pain syndromes, so chronic osteoarthritic pain, as well as chronic lower back pain.”
Start not stated–present
Last confirmed April 30, 2026
Start not stated–present
Last confirmed April 30, 2026
Biotechnology · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Contineum Therapeutics, Inc. (CTNM) | President and Chief Executive Officer | $655,620 | $3,409,448 |
| 2024 | Contineum Therapeutics, Inc. (CTNM) | President and Chief Executive Officer | $608,120 | $4,900,039 |
| 2023 | Contineum Therapeutics, Inc. (CTNM) | President and Chief Executive Officer | $515,595 | $2,315,299 |
